In the midst of the COVID-19 pandemic, we have new appreciation for the role of public health. While our hospitals and other health facilities are turned toward preparing for the worst part of the outbreak in the U.S., we also know that those of you battling C. diff infections still …
Fecal microbiota transplant (FMT) as a treatment for C. difficile infections has skyrocketed over the past decade. While it has saved tens of thousands of lives, FMT remains controversial and the Food and Drug Administration (FDA) has been slow to formalize its regulatory status. This has left doctors, scientists, drug …
In recognition of C. diff Awareness Month, this past November Peggy Lillis Foundation (PLF) launched our new public education campaign, “See C. diff.” The campaign was based from Cdiff.org and included a range of educational media. We are delighted to report that the campaign did incredibly well reaching hundreds of …
On November 13th, the Centers for Disease Control and Prevention released its second Antibiotic Resistance Threats in the United States (AR Threats Report). The report provides new national estimates of deaths and infections caused by antibiotic-resistant germs, and categorizes the top resistant germs based on level of concern to human …
Everyone at Peggy Lillis Foundation (PLF) is very proud of our advocate and C. diff survivor Maryann Webb for her frank and compelling interview on the November 13, 2019 edition of CBS Evening News. Maryann’s story provides a face to the recent Antibiotic Resistant Threats Report. “The U.S. Centers for …
